The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 23. The non-toxicity conclusions for morpholine, methenamine and CAS RN 4174-09-8 are maintained.

Considering all available lines of evidence presented in this screening assessment, there is a low risk of harm to the environment from methenamine, morpholine, and CAS RN 4174-09-8. It is concluded that methenamine, morpholine, and CAS RN 4174-09-8 do not meet the criteria under paragraphs 64(a) or (b)  of CEPA as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.

On the basis of the information presented in this screening assessment, it is concluded that methenamine, morpholine, and CAS RN 4174-09-8 do not meet the criteria under paragraph 64(c) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

It is concluded that methenamine, morpholine, and CAS RN 4174-09-8 do not meet the criteria set out in section 64 of CEPA.

June 7, 2019

Final Screening Assessment Report (FSAR) Published for the CMP-3 Heterocycles Group

The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 23. The non-toxicity conclusions for...
June 5, 2019

Published Results of investigations and recommendations for CMP-2 Flame Retardant (EBTBP), CAS RN 32588-76-4: No Further Action Taken

EBTBP is used in Canada solely as a flame retardant, including in plastic and rubber...
June 5, 2019

Publication of Risk Assessment Results of Investigations and Recommendations for Use of NDSL ATE (CAS RN 3278-89-5)

Current quantities in use in Canada are unlikely to pose a risk to the environment...

The CPCA Compliance Calendar ensures regulatory staff mitigates risk for their companies. Essential information is provided in support of member companies’ ongoing enterprise risk management (ERM) efforts.